Mark R Ziebell is V. P., General Counsel of Avid Bioservices, Inc.. Currently has a direct ownership of 66,799 shares of CDMO, which is worth approximately $665,318. The most recent transaction as insider was on Jun 28, 2024, when has been sold 1,965 shares (Common Stock, $0.001 par value) at a price of $5.41 per share, resulting in proceeds of $10,630. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 66.8K
0% 3M change
10.38% 12M change
Total Value Held $665,318

Mark R Ziebell Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 28 2024
BUY
Other acquisition or disposition
$10,630 $5.41 p/Share
1,965 Added 2.86%
66,799 Common Stock, $0.001 p...
Apr 30 2024
SELL
Open market or private sale
$12,158 $7.4 p/Share
1,643 Reduced 2.47%
64,834 Common Stock, $0.001 p...
Apr 09 2024
BUY
Exercise of conversion of derivative security
-
3,208 Added 4.6%
66,477 Common Stock, $0.001 p...
Jan 10 2024
SELL
Open market or private sale
$8,304 $6.17 p/Share
1,346 Reduced 2.08%
63,269 Common Stock, $0.001 p...
Jan 09 2024
BUY
Exercise of conversion of derivative security
-
3,208 Added 4.73%
64,615 Common Stock, $0.001 p...
Dec 29 2023
BUY
Other acquisition or disposition
$4,932 $5.53 p/Share
892 Added 1.43%
61,407 Common Stock, $0.001 p...
Oct 10 2023
SELL
Open market or private sale
$10,497 $9.2 p/Share
1,141 Reduced 1.85%
60,515 Common Stock, $0.001 p...
Oct 09 2023
BUY
Exercise of conversion of derivative security
-
3,207 Added 4.94%
61,656 Common Stock, $0.001 p...
Jul 11 2023
SELL
Open market or private sale
$69,507 $13.86 p/Share
5,015 Reduced 7.9%
58,449 Common Stock, $0.001 p...
Jul 10 2023
SELL
Open market or private sale
$9,459 $13.77 p/Share
687 Reduced 1.38%
49,173 Common Stock, $0.001 p...
Jul 10 2023
BUY
Exercise of conversion of derivative security
-
14,291 Added 18.38%
63,464 Common Stock, $0.001 p...
Jul 09 2023
BUY
Exercise of conversion of derivative security
-
1,958 Added 3.78%
49,860 Common Stock, $0.001 p...
Jun 30 2023
SELL
Open market or private sale
$17,267 $13.49 p/Share
1,280 Reduced 2.65%
46,975 Common Stock, $0.001 p...
Jun 30 2023
BUY
Other acquisition or disposition
$10,623 $11.46 p/Share
927 Added 1.9%
47,902 Common Stock, $0.001 p...
Jun 29 2023
SELL
Open market or private sale
$30,187 $12.7 p/Share
2,377 Reduced 4.69%
48,255 Common Stock, $0.001 p...
Jun 28 2023
BUY
Exercise of conversion of derivative security
-
10,513 Added 17.19%
50,632 Common Stock, $0.001 p...
May 01 2023
SELL
Open market or private sale
$447,750 $17.91 p/Share
25,000 Reduced 38.39%
40,119 Common Stock, $0.001 p...
May 01 2023
BUY
Exercise of conversion of derivative security
$246,749 $9.87 p/Share
25,000 Added 27.74%
65,119 Common Stock, $0.001 p...
Apr 10 2023
SELL
Open market or private sale
$14,572 $19.8 p/Share
736 Reduced 1.8%
40,119 Common Stock, $0.001 p...
Apr 09 2023
BUY
Exercise of conversion of derivative security
-
1,958 Added 4.57%
40,855 Common Stock, $0.001 p...
Jan 10 2023
SELL
Open market or private sale
$16,606 $14.44 p/Share
1,150 Reduced 2.87%
38,897 Common Stock, $0.001 p...
Jan 09 2023
BUY
Exercise of conversion of derivative security
-
1,957 Added 4.66%
40,047 Common Stock, $0.001 p...
Dec 30 2022
BUY
Other acquisition or disposition
$9,535 $11.7 p/Share
815 Added 2.09%
38,090 Common Stock, $0.001 p...
Oct 09 2022
BUY
Exercise of conversion of derivative security
-
1,957 Added 4.99%
37,275 Common Stock, $0.001 p...
Jul 10 2022
BUY
Exercise of conversion of derivative security
-
14,290 Added 28.81%
35,318 Common Stock, $0.001 p...
MRZ

Mark R Ziebell

V. P., General Counsel
Tustin, CA

Track Institutional and Insider Activities on CDMO

Follow Avid Bioservices, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CDMO shares.

Notify only if

Insider Trading

Get notified when an Avid Bioservices, Inc. insider buys or sells CDMO shares.

Notify only if

News

Receive news related to Avid Bioservices, Inc.

Track Activities on CDMO